PVP Ventures Makes Bold Bet: ₹550 Million Acquisition of Optimus Oncology to Build Healthcare Powerhouse

PVP Ventures Ltd has announced a major strategic move, investing ₹550 million to acquire a 56% stake in Optimus Oncology Pvt Ltd, with plans to increase its holding to 76% in the coming years. This acquisition marks a pivotal step in PVP Ventures’ ambition to create a technology-driven global healthcare services platform focused on illness, wellness, and care.

 

Key Highlights:

 

Majority Stake Acquisition: PVP Ventures will initially acquire a 56% stake in Optimus Oncology through a mix of primary and secondary share purchases, with a total investment of ₹550 million. The company aims to raise its stake to 76% over the next few years, contingent on achieving specific milestones.

 

Growth Platform: The deal aligns with PVP’s strategy to expand aggressively in healthcare, leveraging Optimus Oncology’s expertise and presence in Tier 2 and Tier 3 cities across Maharashtra, with plans to enter Gujarat and Madhya Pradesh.

 

Optimus Oncology Profile: Founded by Tata Memorial Hospital oncologists in 2018, Optimus partners with local hospitals to set up oncology centers, currently operating in Dhule, Latur, Akola, and Solapur. The company reported an EBITDA of over ₹10 crore this year, with projections to reach ₹50 crore in five years.

 

Market Impact: PVP Ventures’ stock surged over 6% following the announcement, reflecting investor confidence in its healthcare-focused growth trajectory.

 

Strategic Vision: Backed by strong real estate assets and anticipated cash flows, PVP Ventures is channeling resources into healthcare, aiming to build a national leader in technology-enabled medical services.

 

Sources: TradingView, MarketScreener, DSIJ